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The Antimicrobial Heterodimer S100A8/S100A9
(Calprotectin) Is Upregulated by Bacterial Flagellin
in Human Epidermal Keratinocytes
Arby Abtin1,4, Leopold Eckhart1, Regine Gla¨ser2, Ramona Gmeiner1, Michael Mildner1 and
Erwin Tschachler1,3
Antimicrobial peptides (AMPs) have a central role in the innate immune system of the skin. Epidermal
keratinocytes (KCs) express numerous such peptides either constitutively or in response to exposure to
microbial compounds. Here, we investigated the regulation of S100A8 (calgranulin A) and S100A9 (calgranulin
B), which form an antimicrobial heterodimeric complex also known as calprotectin, in KCs. Culture
supernatants of Gram-negative bacteria, but not of Gram-positive bacteria nor of the yeast Candida albicans,
triggered the expression of S100A8 and S100A9. To identify pathogen-associated molecular patterns (PAMPs)
responsible for the upregulation of S100A8 and S100A9, KCs were stimulated with ligands for Toll-like receptors
(TLRs). Quantitative real-time PCR (qRT-PCR) analysis revealed that the TLR5 ligand flagellin increased the mRNA
expression of both S100A8 and S100A9. Supernatant from wild-type (WT) Escherichia coli, but not from a
flagellin-deficient E. coli strain (DFliC), induced S100A8 and S100A9 protein production in KCs. Moreover, small
interfering RNA-mediated knockdown of TLR5 expression suppressed the ability of KCs to upregulate S100A8
and S100A9 mRNA expression in response to E. coli supernatant. Like in cell culture, stimulation of human skin
explants with E. coli induced the expression of S100A8 and S100A9. Our data suggest that bacterial flagellin
induces the upregulation of S100A8/S100A9 via a TLR5-dependent mechanism in epidermal KCs.
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INTRODUCTION
The surface of normal human skin is colonized by micro-
organisms; however, it is remarkably resistant to infection by
pathogenic microbes. In addition to the role of the skin as
a mechanical barrier, its protective function in eliminating
potential cutaneous pathogens is partly mediated by the
presence of antimicrobial chemicals, such as antimicrobial
peptides (AMPs) (Schro¨der and Harder, 2006). Epidermal
keratinocytes (KCs) produce a broad range of AMPs including
b-defensins, RNases, cathelicidins, and members of the S100
protein family (Schro¨der and Harder, 2006).
S100 proteins are low molecular weight cationic proteins
characterized by two calcium-binding EF-hand motifs
(Donato, 2001; Eckert et al., 2004). They are involved in
a variety of cellular processes such as calcium-dependent cell
signalling, cell growth and differentiation, cell cycle regu-
lation, and antimicrobial defense (Eckert et al., 2004;
Marenholz et al., 2004; Gla¨ser et al., 2005; Bu¨chau et al.,
2007; Corbin et al., 2008). So far, microbicidal activity has
been described for S100A7c (psoriasin), calprotectin, which
is a heterodimeric complex of S100A8 (calgranulin A, MRP8)
and S100A9 (calgranulin B, MRP14), S100A12 (calgranulin
C), and S100A15 (Sohnle et al., 2000; Cole et al., 2001;
Gla¨ser et al., 2005; Bu¨chau et al., 2007).
The S100A8/S100A9 complex has been shown to exert
antimicrobial activity against bacteria such as Escherichia
coli, Klebsiella spp., Staphylococcus aureus, S. epidermis
(Brandtzaeg et al., 1995), Capnocytophaga sputigena
(Miyasaki et al., 1993), and Borrelia burgdorferi (Lusitani
et al., 2003), as well as fungistatic activity toward the fungus
Candida albicans (Murthy et al., 1993). Various mechanisms
of antimicrobial activity, including the sequestration of
essential trace elements such as Zn2þ or Mn2þ have been
proposed for S100A8/S100A9 (Murthy et al., 1993; Sohnle
et al., 2000; Corbin et al., 2008). Interestingly, Finegoldia
magna, an anaerobic Gram-positive bacterium part of the
normal skin flora, uses its protein L for protection against the
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antimicrobial effect of S100A8/S100A9 (A˚kerstro¨m and
Bjo¨rck, 2009).
Similar to S100A7c, the expression levels of S100A8 and
S100A9 are markedly elevated in involved epidermis of
psoriasis patients (Broome et al., 2003). Similarly, S100A8
and S100A9 are upregulated early during the development of
psoriasis-like lesions in mice lacking epidermal expression of
JunB/c-Jun (Zenz et al., 2005). Cytokines such as interleukin
(IL)-1a, IL-6, IL-8, tumor necrosis factor-a, interferon-a and
-g trigger the upregulation of S100A8 and S100A9 in cultured
KCs (Mork et al., 2003; Nukui et al., 2008).
The innate immune system of the skin is activated, among
other mechanisms, by members of the Toll-like receptor
(TLR) family, which recognize specific microbial components
designated as pathogen-associated molecular patterns (Akira
et al., 2006; Miller and Modlin, 2007). Binding of bacterial
flagellin to TLR5 induces the expression of the AMPs, S100A7c
and hBD-2 (Abtin et al., 2008), thereby protecting the skin
from the flagellated gut bacterium E. coli (Gla¨ser et al., 2005).
The significance of TLR5 for recognition of flagellin-bearing
bacteria was demonstrated in a murine model in vivo, where
Tlr5/ mice were more susceptible to urinary tract infections
caused by uropathogenic E. coli compared with wild-type mice
(Andersen-Nissen et al., 2007).
In this study, we show that S100A8 and S100A9 are
differentially expressed in response to Gram-negative bacteria
and that sensing of bacterial flagellin by TLR5 is critical for the
regulation of S100A8 and S100A9 in epidermal KCs.
RESULTS
S100A8 and S100A9 expression in the epithelium of foreskin,
plantar skin, vulva, and vaginal mucosa
Studies investigating the expression pattern of the antimicro-
bial hBD-2 or S100A7c have found elevated levels of these
AMPs on locations of the skin associated with high microbial
colonization such as in scalp or plantar skin compared with
the skin of other body parts (Ali et al., 2001; Gla¨ser et al.,
2005). To determine the expression pattern of calprotectin
in human skin we performed immunohistochemistry with
mouse monoclonal antibodies directed against its subunits
S100A8 and S100A9. In agreement with previous reports
(Kelly et al., 1989; Broome et al., 2003), S100A8 and S100A9
were found to be absent or expressed at barely detectable
levels in the epidermis of the abdomen (Figure 1a–c). The
epidermis of juvenile foreskin showed a patchy expression of
both S100 proteins (Figure 1d–f). In contrast, the epidermis of
plantar skin as well as the epithelium of the vulva and
mucosa of the vagina expressed high amounts of S100A8
and S100A9, particularly in the upper layers (Figure 1g–o).
Because these sites are highly colonized by bacteria (Wilson,
2005), our findings gave rise to the assumption that
calprotectin expression level is regulated by interactions of
bacteria and KCs.
Gram-negative bacteria induce the expression of S100A8 and
S100A9 in KCs
To test the hypothesis that the expression levels of S100A8
and S100A9 in epidermal KCs is induced by micro-
organisms, human foreskin-derived KCs were exposed to
culture supernatants of Gram-negative bacteria (E. coli,
Pseudomonas aeruginosa and Proteus mirabilis), Gram-
positive bacteria (S. aureus and Enterococcus faecalis) and
of the yeast C. albicans. The expression of S100A8 was
upregulated by E. coli, Ps. aeruginosa and P. mirabilis by
between 20 and more than 60-fold, whereas it was not
altered by exposure to S. aureus, E. Faecalis, or C. albicans.
The expression of S100A9 was increased at least 5-fold by the
three Gram-negative bacteria tested, whereas it was unaffec-
ted by S. aureus and C. albicans. Supernatant from E. faecalis
induced a slight upregulation of S100A9 (Figure 2).
To investigate the capability of live bacteria to regulate
S100A8 and S100A9 under conditions approximating the
in vivo situation, we utilized an ex vivo model of human skin.
E. coli was used as model bacterium as it is pathophysio-
logically relevant for body sites such as the vagina and
because strains carrying targeted genetic modifications
are available (see section ‘Flagellin expression by E. coli is
sufficient for S100A8 and S100A9 induction in KCs‘).
Exposure of skin explants to E. coli increased the expression
of S100A8 and S100A9 proteins, as shown by immunohis-
tochemical analysis (Figure 3). For both S100 proteins,
immunoreactivity was found in a patchy pattern with a
marked expression being detectable in the suprabasal layers
of the epidermis (Figure 3). The data obtained from cultured
KCs (Figure 2) and the ex vivo model of skin explants
demonstrate that KCs respond to E. coli by upregulation of the
S100A8/S100A9 protein complex in vitro and ex vivo.
Flagellin induces the expression of S100A8 and S100A9
Next, we investigated which bacterial components might
be responsible for the regulation of S100A8 and S100A9.
As Toll-like receptors (TLRs) recognize distinct pathogen-
associated molecular patterns and subsequently trigger the
activation of innate immune responses (Akira et al., 2006),
foreskin-derived KCs were stimulated for 16 hours with IL-1a
and bacterial ligands of TLRs that are expressed by KCs
(Ko¨llisch et al., 2005; Lebre et al., 2007), that is, TLRs 1, 2, 4,
5, 6, and 9. qRT-PCR analysis showed that the mRNA
expression levels of S100A8 and S100A9 were upregulated
by the TLR5 ligand flagellin, but not by other TLR ligands
(Figure 4a). The levels of upregulation were comparable
with that induced by IL-1a stimulation (Figure 4a). In dose–
response experiments we found that a concentration of
10 ng ml–1 of flagellin was sufficient to achieve a maximum
upregulation of S100A8 and S100A9 mRNA (data not
shown). To test whether the induction of mRNAs lead to
increased protein levels, KCs were stimulated with flagellin
for 48 hours and analyzed by immunoblotting. Indeed, both
treatments with IL-1a and flagellin elevated the amounts of
S100A8 and S100A9 proteins (Figure 4b). In contrast,
stimulation with ligands, that mimic virus-derived nucleic
acids (ligands for TLR3, 7 and 8), did not induce S100A8 or
S100A9 mRNA expression levels (Supplementary Figure S1
online).
To investigate the regulation of S100A8 and S100A9
in differentiated KCs, three-dimensional organotypic skin
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cultures were stimulated with flagellin or were left untreated
(Supplementary Figure S2 online). Although already the
control skin equivalents produced substantial amounts of
S100A8 and S100A9 under the given culture conditions,
treatment with flagellin further increased the expression of
these proteins, as demonstrated by immunohistochemical
and immunoblot analysis (Supplementary Figure S2 online).
These data demonstrated that flagellin is able to induce
S100A8 and S100A9 expression both in proliferating KCs
in monolayer cultures as well as in differentiated KCs in
organotypic skin cultures.
Flagellin expression by E. coli is sufficient for S100A8 and
S100A9 induction in KCs
Then, we investigated the relative contribution of flagellin
to the induction of S100A8/S100A9 by E. coli. A wild-type
flagellated E. coli strain (NK 9373) and a flagellin-deficient
(DFliC) E. coli strain (NK 9375) were compared with regard to
their capacity to upregulate S100A8 and S100A9 expression.
Immunoblot analysis revealed that in contrast to the wild-type
strain, E. coli DFliC was unable to induce the expression of
S100A8 and S100A9 proteins (Figure 5) corresponding to the
previously obtained results for S100A7c induction by E. coli
(Abtin et al., 2008). Addition of flagellin to E. coli DFliC culture
supernatant restored the ability to induce both S100 proteins
production. This finding suggests that flagellin is essential for
E. coli-mediated induction of S100A8/S100A9 in KCs.
E. coli-mediated induction of S100A8 and S100A9 is
TLR5-dependent
To investigate how KCs sense E. coli-derived flagellin in the
course of S100A8/S100A9 induction, foreskin-derived KCs
Isotype
Abdomen
Foreskin
Plantar
Vulva
Vaginal
mucosa
S100A8 S100A9
Figure 1. Differential expression of S100A8 and S100A9 proteins by epithelial cells. Human tissue samples of the abdomen (a–c), foreskin (4-year-old
subject, d–f), plantar (g–i), vulva (j–l), and vaginal mucosa (m–o) were processed for immunohistochemistry with mouse monoclonal anti-S100A8 or mouse
monoclonal anti-S100A9 antibodies and an appropriate isotype control antibody as indicated. Scale bars¼ 100 mm.
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were treated with TLR5-specific siRNA and with control
siRNA before stimulation of the cells with E. coli culture
supernatants. As we have shown previously, transfection of
KCs with TLR5 siRNA leads to a downregulation of TLR5
mRNA by approximately 70% as compared to transfection
with control siRNA (Abtin et al., 2008). KCs with reduced
TLR5 expression were unable to upregulate S100A8 and
S100A9 mRNA by stimulation with purified flagellin
(Supplementary Figure S3 online) confirming the functional
inactivation of TLR5 signaling by the siRNA treatment. The
knockdown of TLR5 inhibited the induction of S100A8 and
S100A9 mRNA expression by E. coli, whereas it did not cause
a significant change in the response to DFliC E. coli (Figure 6).
Taken together, these data suggest that TLR5-mediated
binding of flagellin and the induction of signaling events
downstream of TLR5 are essential for S100A8/S100A9
upregulation in response to E. coli.
DISCUSSION
The protein dimer S100A8/S100A9 has been implicated to
have a major role in inflammatory and anti-infectious
processes of skin by the observation that this complex is
highly elevated in psoriatic epidermis (Brandtzaeg et al.,
1987; Broome et al., 2003) and by its inducibility by
pro-inflammatory cytokines (Mork et al., 2003; Nukui et al.,
2008). However, whether distinct microbial components
trigger S100A8 and S100A9 expression had remained elusive.
Here, we have identified flagellin, a component of flagellated
bacteria as a principal bacterial-derived inductive factor
of S100A8 and S100A9 expression in KCs.
Culture supernatants of flagellated bacteria such as E. coli
or Ps. aeruginosa strongly enhanced the expression of
S100A8 and S100A9, yet the Gram-positive bacteria
S. aureus or E. faecalis and the yeast C. albicans had no or
only a weak effect. A key result of our investigation was
that flagellin expression by E. coli was associated with the
regulation of S100A8 and S100A9 by demonstrating that
a flagellin-deficient E. coli strain (DFliC) was unable to
upregulate the expression of S100A8 and S100A9 compared
to its wild-type strain. The finding that flagellin induces
S100A8 and S100A9 expression and the data observed with
the flagellin-deficient E. coli strain suggest that flagellin is the
main component of E. coli, and perhaps other flagellated
bacteria, accountable for S100A8 and S100A9 stimulation in
KCs. Although it is difficult to estimate the concentration of
flagellin on the skin surface, it is likely that focal growth of
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Figure 2. Gram-negative bacteria induce the expression of S100A8 and
S100A9. (a) Normal human foreskin-derived epidermal KCs were stimulated
for 48 hours with IL-1a (10 ng ml–1) and culture supernatants of E. coli,
Ps. aeruginosa, P. mirabilis, S. aureus, E. faecalis, and C. albicans as described
in the Materials and Methods section. After stimulation, cell lysates were
subjected to immunoblot analysis with anti-S100A8 or anti-S100A9
antibodies. Immunoblot with anti-GAPDH antibody served as loading control
for protein lysates. (b) Quantification of immunoblots in a of S100A8
and S100A9 protein expression relative to GAPDH, respectively, by
densitometric analysis.
Untreated
S100A8
S100A9 S100A9
S100A8
E. coli
Figure 3. Ex vivo stimulation of human skin with E. coli increases the
expression of S100A8 and S100A9. Normal human skin explants of
abdominal origin (n¼2) were stimulated with live E. coli for 53 hours or
were left untreated as described in the Materials and Methods section.
Afterwards skin biopsies were processed for immunohistochemistry analysis
with mouse monoclonal antibodies directed against S100A8 or S100A9
proteins. Scale bars¼100 mm.
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flagellated bacteria will be associated with sufficiently high
concentrations of flagellin. This was supported by our studies
on human skin explants, but needs to be investigated in
further in vivo studies.
With regard to possible mechanisms of upregulation of
S100A8 and S100A9, we have identified the flagellin
receptor TLR5 as an essential element of sensory and signal-
ing system for E. coli. By using RNA interference technology,
knockdown of TLR5 in KCs dramatically reduced respon-
siveness to E. coli, suggesting that the presence of E. coli
is recognized by TLR5, and therefore a successful response
is TLR5-dependent. Although we have not formally demon-
strated that flagellin and TLR5 have similar roles in sensing
other flagellated Gram-negative bacteria, it is likely that
TLR5-mediated detection of flagellin is of general importance
for the induction of S100A8 and S100A9 expression by
bacteria.
Our investigation extends the range of AMPs that are
induced by flagellin in KCs. Previously, S100A7c, S100A15
and hBD-2 were shown to be regulated by flagellin
(Miller et al., 2005; Abtin et al., 2008). These AMPs have
antimicrobial activity profile different from that of S100A8/
S100A9. However, some bacteria are susceptible to killing by
both S100A8/S100A9 and other flagellin-inducible factors
(Brandtzaeg et al., 1995; Gla¨ser et al., 2005; Schro¨der and
Harder, 2006; Abtin et al., 2008), indicating that AMPs
synergize in the protection and/or elimination of cutaneous
pathogens.
In our ex vivo model, we found that contact of skin
explants with live E. coli triggered the production of both
S100 proteins in a patchy manner. This finding fits well with
the previously reported localized expression pattern of hBD-2
or S100A7c (Ali et al., 2001; Gla¨ser et al., 2005), pointing
out that focal microbial growth is recognized and sensed by
KCs along with defensive countermeasures. The reports of
earlier studies regarding the protective functions of S100A8/
S100A9 (Murthy et al., 1993; Brandtzaeg et al., 1995;
Nisapakultorn et al., 2001; Corbin et al., 2008; Zaia et al.,
2009) supplemented with the data presented here concerning
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Figure 4. Flagellin induces S100A8 and S100A9 expression. (a) Normal
human foreskin-derived epidermal KCs were stimulated for 16 hours with
IL-1a (10 ng ml–1) and the following TLR ligands: 0.5 mg ml–1 Pam3CSK4
(TLR1/2 ligand), 108 cells per ml HKLM (TLR2 ligand), 100 ng ml–1 LPS (TLR4
ligand), 0.5mg ml–1 flagellin (TLR5 ligand), 0.5 mg ml–1 FSL1 (TLR6/2 ligand),
and 2.5 mM ODN2006 (TLR9 ligand). The relative S100A8 and S100A9 gene
expression levels were quantified by real-time PCR and normalized to the
expression of the housekeeping gene b-2-microglobulin. The mean values are
displayed in relation to untreated controls. Data represent the mean±s.d.
*Po0.05 versus untreated control; unpaired Student’s t-test. (b) KCs were
stimulated for 48 hours with IL-1a and flagellin (both 10 ng ml–1). Afterwards
cell lysates were subjected to immunoblot analysis with anti-S100A8 or
anti-S100A9 antibodies. Anti-GAPDH immunoblot served as equal loading
control for protein lysates.
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Figure 5. Flagellin-dependent induction of S100A8 and S100A9 by E. coli
culture supernatant. Normal human foreskin-derived epidermal KCs
were stimulated for 48 hours with flagellin (10 ng ml–1) and/or culture
supernatants from wild-type (WT) and DFliC E. coli as described in the
Materials and Methods section. Cell lysates were analysed by immunoblot
specific for S100A8 and S100A9. Equal loading of lanes was confirmed by
anti-GAPDH immunoblot.
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the mechanism of induction and regulation, indicate this
protein complex as an additional important component of the
early host defence to microbial colonization and/or infection
of human skin.
MATERIALS AND METHODS
Cell culture
Human primary KCs prepared from neonatal foreskin were obtained
from Clonetics (San Diego, CA) and cultured in serum-free KCs
growth medium, which is composed of KCs basal medium (KBM)
supplemented with 0.1 ng ml–1 human recombinant epidermal
growth factor, 5mg ml–1 insulin, 0.5 mg ml–1 hydrocortisone, 0.4%
bovine pituitary extract, 50mg ml–1 gentamicin, and 50 ng ml–1
amphotericin B (Clonetics), as described previously (Rendl et al.,
2002). For stimulation, third passage KCs were cultured in 12-well
tissue culture plates (Corning, NY) and used at a confluence of
60–70%. Stimulation was performed in KBM.
Human dermal fibroblasts were obtained from Cascade
(Portland, OR) and cultured in Dulbecco’s modified Eagle’s medium
(DMEM, Gibco BRL, Gaithersburg) supplemented with 10% fetal
bovine serum (FBS, PAA, Linz, Austria), 25 mM L-glutamine (Gibco)
and 1% penicillin/streptomycin (Gibco).
Preparation of organotypic skin cultures
In vitro organotypic skin cultures were generated as described
previously (Mildner et al., 2006). Organotypic skin cultures were left
untreated or were stimulated with flagellin (1 mg ml–1) on day 5 of
air–liquid interface for 48 hours.
Reagents used for KCs treatment
For in vitro assays recombinant interleukin-1a (IL-1a; R&D Systems,
Minneapolis, MN) and the following Toll-like receptors (TLRs)
ligands (Invivogen, San Diego, CA) were used: synthetic tripalmi-
toylated lipopeptide (Pam3CSK4, TLR1/2 ligand), heat killed Listeria
monocytogenes (HKLM, TLR2 ligand), poly (I/C), a synthetic analog
of double-stranded RNA (TLR3 ligand), ultra-pure LPS from
E. coli K12 (TLR4 ligand), purified flagellin from Salmonella
typhimurium (TLR5 ligand), synthetic lipoprotein of Mycoplasma
salivarium (FSL1, TLR6/2 ligand), imiquimod (R837, TLR7 ligand),
single-stranded RNA40 (TLR8 ligand) and ODN2006 (CpG oligo-
nucleotide type B, TLR9 ligand).
RNA isolation and quantitative real-time PCR
After stimulation, cells were washed with phosphate-buffered saline
(PBS) and RNA was isolated using TRIzol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions.
For cDNA synthesis, RNA was reverse-transcribed with the murine
leukemia virus reverse transcriptase using the Gene Amp RNA PCR
kit (Applied Biosystems, Foster City, CA) and oligo dT primers
(Roche Diagnostics, Basel, Switzerland). cDNA sequences of the
genes under investigation were obtained from the GenBank. Primers
were designed using the PRIMER3 software from the Whitehead
Institute for Biomedical Research (Cambridge, MA). The following
forward (F) and reverse (R) intron-spanning primers were used
for b-2-microglobulin: F, 50-GATGAGTATGCCTGCCGTGTG-30; R,
50-CAATCCAAATGCGGCATCT-30; S100A8: F, 50-ATGCCGTCTAC
AGGGATGAC-30; R, 50-ACGCCCATCTTTATCACCAG-30; S100A9: F,
50-TCATCAACACCTTCCACCAA-30; R, 50-GTGTCCAGGTCCTCCAT
GAT-30.
qRT-PCR was performed by LightCycler technology using the
Fast Start SYBR Green I kit for amplification and detection
(Roche Diagnostics) as described previously (Abtin et al., 2009).
Relative quantification of target gene expression and amplification
efficiencies were performed using a mathematical model as
described by Pfaffl (Pfaffl, 2001). The expression of the target genes
was normalized to the expression of the housekeeping gene b-2-
microglobulin. All real-time PCRs were performed in triplicate.
The specificity of the reactions was confirmed by sequencing of
the PCR products.
Bacterial strains and KCs stimulation
E. coli NK 9373 and E. coli NK 9375 (DFliC; a flagellin-deficient
strain having an in-frame deletion within the fliC gene) (Bates et al.,
2005) were kindly provided by Dr D Bates (Baylor College
of Medicine, Houston, TX). Culture supernatants of Ps. aeruginosa
(ATCC 27853), P. mirabilis (clinical isolate), methicillin-resistant S.
aureus (MRSA; ATCC 33592), E. faecalis (clinical isolate), C.
albicans (ATCC 90028) and the above-mentioned E. coli strains
were used for KCs stimulation. The microorganisms were grown in
tryptic soy broth (TSB; Fluka, Buchs, Switzerland) with agitation at
371C until an optical density at 600 nm (OD600) of 1.0 was reached.
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Figure 6. Induction of S100A8 and S100A9 by E. coli is mediated by TLR5.
Normal human foreskin-derived epidermal KCs were transfected either with
scrambled (SCR; black bars) or TLR5 siRNA (white bars). Forty-eight hours
after transfection, cells were stimulated for 16 hours with wild-type or DFliC
E. coli culture supernatants. After stimulation, total RNA was harvested
and reverse-transcribed to cDNA. Relative S100A8 and S100A9 gene
expression levels were quantified by real-time PCR. The results were
normalized to the expression of the housekeeping gene b-2-microglobulin.
The mean values are displayed in relation to controls. Data represent the
mean±s.d. *Po0.05 determined by Student’s t-test.
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Then 1 ml of this culture was combined with 9 ml of TSB and
incubated overnight in 75-cm2 flasks (Cellstar, Frickenhausen,
Germany) at 371C without agitation. Cultures were diluted with
TSB to an OD600 of 1.7. Subsequently, microbial suspensions
were heated in a water bath at 651C for 60 min to kill bacteria.
Heat-killing was verified by plating culture on Luria-Bertani (LB)
agar. After heat-killing, cultures were centrifuged at 5000 g for
15 min. The resulting supernatants were diluted 1:1000 in KBM
and used to stimulate KCs from which the previous medium had
been removed. Unconditioned TSB was diluted 1:1,000 in KBM as
control.
siRNAs transfections
The siRNA transfection was performed as described previously
(Abtin et al., 2008).
Immunoblot analysis
For analysis of protein expression, KCs or organotypic skin cultures
were lyzed in a buffer containing 50 mM Tris, pH 7.4, and 2% SDS.
After sonication insoluble cell debris was removed by centrifugation
and the protein concentration was measured by the BCA (bicinch-
oninic acid) method (Pierce, Rockford, IL). Immunoblot analysis
was performed as described previously (Mildner et al., 2006). The
following first step antibodies were used: mouse monoclonal IgG1
anti-S100A8 clone S13.67 (dilution 1:500; Acris, Hiddenhausen,
Germany), mouse monoclonal IgG1 anti-S100A9 clone 47-8D3
(dilution 1:500; Abcam, Cambridge, UK) and mouse monoclonal
IgG2b anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(dilution 1:2000; Biogenesis, Poole, UK). The membranes were
developed using the Chemiglow reagent (Alphainnotech, San
Leandro, CA) according to the manufacturer’s instructions. For
quantitative analysis of protein expression, the intensities of western
blot bands were determined by densitometry.
Immunohistochemical analysis
Human normal abdominal skin samples (five subjects) were
obtained from plastic surgery and plantar skin samples (five subjects)
were derived from unaffected skin from the surgical margins around
benign skin lesions (such as melanocytic nevi), kindly provided by
the Department of Plastic Surgery or Department of Pathology of the
Medical University of Vienna, Austria. Specimens of normal tissue
samples of the vulva (five subjects) or mucosal epithelium of the
vagina (three subjects) were obtained from the tissue bank of the
Department of Pathology (kindly provided by Johannes Pammer).
Foreskin tissue samples (from subjects aged 10 months and 4 years,
respectively) were kindly provided by Andrea Trost, Department of
Dermatology, University of Salzburg, Austria. Studies with human
tissues were done in agreement with the guidelines of the Medical
University of Vienna and the University of Salzburg and according to
the Helsinki protocol. Immunohistochemical analysis was performed
on paraffin-embedded, formalin-fixed skin sections or organotypic
skin cultures (4mm) using the ready-to-use UltraVision Detection
System kit (Thermo Fisher Scientific, Fremont, CA) according to the
manufacturer’s instructions. The above mentioned mouse mono-
clonal anti-S100A8, anti-S100A9 and a mouse IgG isotype control
(Dako, Glostrup, Denmark) were used as primary antibodies. The
antibodies were diluted to 2 mg ml–1 in 2% BSA/PBS and applied
overnight on sections at 41C. The Liquid Fast-Red substrate system
(Thermo Fisher Scientific) was used as the chromogen. Sections were
counter-stained with hematoxylin.
Ex vivo stimulation of human skin
The study was approved by the University committee for ethical affairs
Kiel (AZ A 104/06) in accordance with the Helsinki guidelines, and all
participants included in this investigation provided written informed
consent. Samples of abdominal skin that had been excised from two
subjects in the course of plastic surgery involving standard disinfection
of the skin surface were kindly provided by C. Preissner (Vital-
Aesthetic-Clinic Kiel, Germany). Fresh tissues were transferred into
PBS and processed immediately. After mechanical removal of
subcutaneous fat, skin explants were washed twice with PBS and
placed in sterile Petri dishes into DMEM medium (Cell Concepts
GmbH, Umkirch, Germany). The explants were than incubated for
2 hours at room temperature and after that exposed to living E. coli
ATCC 35218. One colony derived after overnight culture at 371C on
blood agar plates was applied on one square centimetre of skin.
Untreated skin served as a control. Incubation was performed for
53 hours at room temperature in a humidified atmosphere. After
incubation, skin was removed from medium; punch biopsies (6 mm)
were taken, fixed in 4% formalin and embedded in paraffin. Sections
were subjected to immunohistochemistry as described above.
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